Get the Stockscreener App
5.34
0.93%
-0.05
After Hours:
5.34
Curevac N V stock is traded at $5.34, with a volume of 1.22M.
It is down -0.93% in the last 24 hours and down -2.38% over the past month.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
See More
Previous Close:
$5.39
Open:
$5.39
24h Volume:
1.22M
Relative Volume:
1.05
Market Cap:
$1.20B
Revenue:
$596.48M
Net Income/Loss:
$123.72M
P/E Ratio:
9.7374
EPS:
0.5484
Net Cash Flow:
$106.59M
1W Performance:
-0.93%
1M Performance:
-2.38%
6M Performance:
+68.45%
1Y Performance:
+72.82%
1-Day Range:
$5.32
$5.40
1-Week Range:
$5.32
$5.41
52-Week Range:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
Compare CVAC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.34 | 1.21B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-08-23 | Initiated | SVB Securities | Outperform |
| Jan-19-23 | Upgrade | UBS | Neutral → Buy |
| Jan-09-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-18-22 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Hold |
| Jun-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-26-21 | Resumed | Credit Suisse | Underperform |
| Apr-26-21 | Initiated | Guggenheim | Neutral |
| Dec-10-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-08-20 | Initiated | BofA Securities | Buy |
| Sep-08-20 | Initiated | Credit Suisse | Neutral |
| Sep-08-20 | Initiated | Jefferies | Hold |
View All
Curevac N V Stock (CVAC) Latest News
Nuveen LLC Takes Position in CureVac N.V. $CVAC - MarketBeat
Is It Too Early to Call Recovery in CureVac N.V.Market Volume Report & Verified Swing Trading Watchlist - beatles.ru
Can CureVac N.V. ride the EV waveMarket Volume Summary & Low Risk High Reward Ideas - beatles.ru
Is CureVac N.V. being accumulated by smart moneyWeekly Stock Report & Long-Term Investment Growth Plans - beatles.ru
How to build a custom watchlist for CureVac N.V.July 2025 Fed Impact & Stepwise Trade Signal Guides - Newser
Does CureVac N.V. offer margin of safetyJuly 2025 Chart Watch & High Conviction Buy Zone Picks - classian.co.kr
State of Wyoming Buys New Shares in CureVac N.V. $CVAC - MarketBeat
How sensitive is CureVac N.V. to inflationJuly 2025 Spike Watch & Real-Time Volume Analysis Alerts - خودرو بانک
Chart based exit strategy for CureVac N.V.Earnings Summary Report & Reliable Intraday Trade Alerts - Newser
Does CureVac N.V. qualify in momentum factor screeningMarket Trend Summary & Entry Point Confirmation Alerts - Newser
What does recent volatility data suggest for CureVac N.V.2025 Market Overview & Verified High Yield Trade Plans - Newser
How to integrate CureVac N.V. into portfolio analysis toolsDay Trade & Real-Time Stock Price Movement Reports - Newser
Can CureVac N.V. deliver consistent EPS growthMarket Sentiment Review & Stepwise Entry and Exit Trade Signals - خودرو بانک
Ranking CureVac N.V. among high performing stocks via toolsEntry Point & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-05 06:45:53 - Newser
What Fibonacci levels say about CureVac N.V. reboundWeekly Trade Review & Smart Investment Allocation Tips - Newser
Measuring CureVac N.V.’s beta against major indicesJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Developing predictive dashboards with CureVac N.V. dataJuly 2025 Trends & Growth Oriented Trade Recommendations - Newser
Real time alert setup for CureVac N.V. performanceTrend Reversal & Verified Technical Signals - Newser
Key metrics from CureVac N.V.’s quarterly dataTrade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Key resistance and support levels for CureVac N.V.2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
Is CureVac N.V. stock a falling knife or bargain buy2025 Short Interest & Stepwise Entry and Exit Trade Signals - خودرو بانک
Does CureVac N.V. have high return on assets2025 Winners & Losers & Safe Capital Growth Tips - خودرو بانک
Strategies to average down on CureVac N.V.2025 Risk Factors & Low Risk High Reward Ideas - Newser
Institutional scanner results for CureVac N.V.July 2025 Snapshot & High Accuracy Trade Alerts - Newser
Forecasting CureVac N.V. price range with options dataInsider Buying & Fast Gain Stock Trading Tips - Newser
Is CureVac N.V. forming a breakout patternJuly 2025 Breakouts & Weekly Return Optimization Alerts - خودرو بانک
CureVac N.V. recovery potential after sell off2025 Major Catalysts & Community Trade Idea Sharing - Newser
Can a trend reversal in CureVac N.V. lead to recoveryPortfolio Gains Summary & Daily Chart Pattern Signals - Newser
CureVac N.V. stock daily chart insightsWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can CureVac N.V. keep up with sector leadersJuly 2025 Drop Watch & Expert Curated Trade Ideas - خودرو بانک
CureVac N.V. Reaches Critical Trendline Support2025 Earnings Surprises & Comprehensive Market Scan Insights - beatles.ru
How does CureVac N.V. compare to its peers2025 Trade Ideas & Weekly Market Pulse Updates - خودرو بانک
Is CureVac N.V. affected by consumer sentiment2025 Market Overview & Verified Chart Pattern Signals - خودرو بانک
Does CureVac N.V. have pricing powerWeekly Stock Analysis & Daily Entry Point Alerts - خودرو بانک
Is CureVac N.V. stock bottoming outPortfolio Update Report & Verified Momentum Watchlists - Newser
Can CureVac N.V. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - 강소기업뉴스
Automated trading signals detected on CureVac N.V.July 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
CureVac N.V. stock outlook for YEARQuarterly Portfolio Report & Smart Investment Allocation Insights - Newser
Curevac N V Stock (CVAC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):